Risk factors for dysplasia in patients with Barrett's esophagus (BE): Results from a multicenter consortium

Digestive Diseases and Sciences

Volumn 48, Issue 8, 2003, Pages 1537-1541

  Gopal, Deepak V ^a,d   Lieberman, David A ^a   Magaret, Nathan ^a   Fennerty, M Brian ^a   Sampliner, Richard E ^b   Garewal, Harinder S ^b   Falk, Gary W ^c   Faigel, Douglas O ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d University of Wisconsin Health   (United States)

Author keywords

Age; Barrett's esophagus; COBE; Cooperative Study of Barrett's Esophagus; Dysplasia; Length; Prevalence

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER EPIDEMIOLOGY; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM DYSPLASIA; ESOPHAGUS MUCOSA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX RATIO;

ADENOCARCINOMA; AGE FACTORS; AGED; BARRETT ESOPHAGUS; CELL TRANSFORMATION, NEOPLASTIC; CROSS-SECTIONAL STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; REGISTRIES; RISK FACTORS; SEX FACTORS;

EID: 0042200464     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024715824149     Document Type: Article

References (21)

1. Cameron AJ, Lomboy CT: Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 103:1241, 1992
2. Sampliner RE: Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 93:1028, 1998
3. Rustgi AK: Biomarkers for malignancy in the columnar-lined esophagus. Gastroenterol Clin North Am 26:599, 1997
4. Spechler SJ: Barrett's esophagus. Semin Gastrointest Dis 7:51, 1996
5. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, et al: Observer variation in the diagnosis of dysplasia in barrett's esophagus. Hum Pathol 19:166-178, 1988
6. Spechler SJ: Complications of gastroesophageal reflux disease. In The Esophagus, 2nd ed, DO Castell (ed). Boston, Little Brown, p 533, 1995
7. Cameron AJ, Ott BJ, Payne WS: The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313:857, 1985
8. Spechler SJ: The frequency of esophageal cancer in patients with Barrett's esophagus. Acta Endosc 22:541, 1992
9. Drewitz DJ, Sampliner RE, Garewal HS: The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92:212, 1997
10. O'Connor JB, Falk GW, Richter JE: The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 94:2037-2042, 1999
11. Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D: The Development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 93:536-541, 1998
12. Provenzale D, Schmitt C, Wong JB: Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 94:2043, 1999
13. Van der Veen AH, Dees J, Blankensteijn JD, Van Blankenstein M: Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut 30:14, 1989
14. Streitz JM Jr, Ellis FH, Tilden RL, Erickson RV: Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol 93:911, 1998
15. Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE: Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol 92:2012-2016, 1997
16. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RKH: Specialized Intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 116:277-285, 1999
17. Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS, Reid BJ: Effect of segment length on risk for neoplastic progression in patients with Barrett's esophagus. Ann Intern Med 132:612-620, 2000
18. Alikhan M, Rex D, Khan A, Rahmani E, Cummings O, Ulbright TM: Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointest Endosc 50:23, 1999
19. Reid BJ, Weinstein WM, Lewin KJ, Haggitt RC, VanDeventer G, DenBesten L, Rubin CE: Endoscopic Biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 94:81-90, 1988
20. Sagan C, Flejou JF, Diebold MD, Potet F, Le Bodic MF: Reproducibility of histological criteria of dysplasia in Barretts mucosa. Gastroentrol Clin Biol 18:D31-D34, 1994 (in French)
21. Sampliner RE, Garewal HS, Fennerty MB, Aickin M: Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 35:93-96, 1990